Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Shelley Wood

May 25, 2016

News Daily News

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Shelley Wood

March 07, 2016

News Conference News ISC 2016

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Todd Neale

February 16, 2016

News Features

Possible Turf War Brewing Over Delivery of Acute Stroke Interventions

Todd Neale

December 28, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Daily News

Endovascular Treatment Shows Dramatic Benefits for Large Strokes in 3 Trials

Todd Neale

February 11, 2015

News Daily News

Registry Study Confirms That Faster Thrombolysis Improves Stroke Outcomes

June 28, 2013

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

Advertisement

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Possible Turf War Brewing Over Delivery of Acute Stroke Interventions

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Endovascular Treatment Shows Dramatic Benefits for Large Strokes in 3 Trials

Registry Study Confirms That Faster Thrombolysis Improves Stroke Outcomes

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content